Replies to post #443991 on Anavex Life Sciences Corp (AVXL)

[williamssc]

Well then proclaiming failure is silly too. Avatar was reported as primary and secondary efficacy end points being met.

"Efficacy endpoints demonstrated statistically significant and clinically meaningful reductions in Rett syndrome symptoms with related changes in potential biomarkers (GABA and L-AAA) of disease pathology"

I look forward to the EXCELLENCE results.